摘要
目前肺癌的诊断主要依靠血清中肿瘤标志物的联合检测。肿瘤标志物对肺癌的诊断有一定的临床价值。现综述肺癌联合检测血清肿瘤标志物以寻找最佳肿瘤标志物组合,从而提高肺癌的诊断水平。
At present,the diagnosis of lung cancer is focused on combining assay of serum tumor markers . Combined detection of tumor marteers for lung cancer was revewed.
出处
《现代肿瘤医学》
CAS
2008年第4期645-648,共4页
Journal of Modern Oncology